AAPM&R Annual Assembly 2020 Archives - Page 10 of 49

Body Awareness in Patients Treated with Osteopathic Manipulative Treatment for Pain: A Pilot Study
Danielle K. Emmet, DO (Prelim in IM, Westchester Medical Center, NY. Future PM&R Resident at Columbia-Cornell New York Presbyterian., Baltimore, Maryland); Jay H. Shubrook, DO; Wolf Mehling, MD; Stacey Pierce-Talsma, DO
Body Functions of Individuals with Poly-Trauma and Chronic Pain
Armando S. Miciano, Jr., MD (Nevada Rehabilitation Institute, Las Vegas, Nevada); Chad L. Cross, PhD, MFT, PStat(R), C-MDI
BOOST Camp – A Novel Outpatient Rehabilitation Program for Patients with Limb Loss
Tawnee L. Sparling, MD (Spaulding Rehabilitation Hospital/Harvard Medical School PM&R Program, Boston, Massachusetts); David Crandell, MD; Urvashi Chogle, Physical Therapist
Botulinum Toxin Treatment for Focal Dystonia Secondary to Novel CACNA1A Gene Mutation: A Case Report
Bridget B. Walker, MD (Rochester Regional Health, Rochester, New York); Nicholas Ketchum, MD
Botulinum Toxin Type A Induced Trapezius Atrophy: A Case Report
Jonathan Koehler (Texas College of Osteopathic Medicine, Fort Worth, Texas); Sajid A. Surve, DO, FAOCPMR; Andrew Kramer, BS
Botulinum Toxin Type a Overdoses and Associations with Medication Errors
Rashid Kazerooni, PharmD, MS, BCPS (Merz North America, Raleigh, North Carolina)
Cachexia Syndrome Impacts Cancer Patient Discharge Disposition After Inpatient Rehabilitation
Ishan Roy, MD, PhD (McGaw Medical Center of Northwestern University (SRAlab) PM&R Program, Chicago, Illinois); Prakash Jayabalan, MD, PhD; Akash Bhakta, DO, MHA; Emily R. Marquez, MD; Kevin I. Huang, DO; Jacqueline Spangenberg, BS
Can Acute Inflammatory Demyelinating Polyneuropathy Be Triggered by an Acute Syphilis Infection: A Case Report
Naveen S. Khokhar, DO (Vidant Medical Center/East Carolina University PM&R Program, Greenville, North Carolina)
Case Report: Atypical Hand Dystonia After Polytrauma
Ady M. Correa-Mendoza, MD (VA Caribbean Healthcare System PM&R Program, San Juan); Keryl Motta-Valencia, MD; Rocio Delgado-Diaz, MD; Francisco J. Irizarry-Rivera, MD
Case Report: Fluoroquinolone Induced Guillain-Barré Syndrome
Meghan A. Klawonn, MD, BS (State University of New York (SUNY) Upstate Medical University PM&R Program, Syracuse, New York); Andreea Nitu-Marquise, MD